Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Detection and analysis of circulating large intergenic non‐coding RNA regulator of reprogramming in plasma for breast cancer

1 Nov 2017

Abstract excerpt

Background Previous studies have indicated that large intergenic non‐coding RNA regulator of reprogramming (lincRNA‐ROR) plays an important role in regulating tumor carcinogenesis and metastasis; however, whether circulating lincRNA‐ROR could function as a potential biomarker for breast cancer (BC) diagnosis and monitoring is unknown. This study was conducted to investigate circulating lincRNA‐ROR in plasma as a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related molecular mechanisms research
Share to Ferroptosis and cancer prognosis
Share to RNA Research and Splicing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29090518
DOI: 10.1111/1759-7714.12537

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Detection and analysis of circulating large intergenic non‐coding RNA regulator of reprogramming in plasma for breast cancerPMID 29090518Read ↗

Large intergenic non-coding RNA-ROR as a potential biomarker for the diagnosis and dynamic monitoring of breast cancerSemantic proximity Read ↗

Transcriptomic insights into the development and therapy of breast cancer via the ncRNA-mediated ceRNA regulation networkSemantic proximity Read ↗

Long Non-Coding RNAs as New Master Regulators of Resistance to Systemic Treatments in Breast CancerSemantic proximity Read ↗

Circulating non-coding RNAs as a diagnostic and management biomarker for breast cancer: current insights.Semantic proximity Read ↗

Long Non-Coding RNA: Dual Effects on Breast Cancer Metastasis and Clinical ApplicationsSemantic proximity Read ↗

Long non-coding RNAs as monitoring tools and therapeutic targets in breast cancerSemantic proximity Read ↗

Long noncoding RNA DLEU2 and ROR1 pathway induces epithelial-to-mesenchymal transition and cancer stem cells in breast cancerSemantic proximity Read ↗

Functional Variants in Linc-ROR are Associated with mRNA Expression of Linc-ROR and Breast Cancer Susceptibility.Semantic proximity Read ↗

A three-long noncoding RNA signature as a diagnostic biomarker for differentiating between triple-negative and non-triple-negative breast cancersSemantic proximity Read ↗

Dysregulation of lncRNA LINC00968 may contribute to the tumorigenesis of estrogen receptor-positive (ER+) breast cancerSemantic proximity Read ↗

LNC01089-LINC00963/miR-1244-5p/IGF1 ceRNA axis might regulate FOXO signaling pathway in breast cancer patients: a biomarker discovery investigationSemantic proximity Read ↗

Predictive and Prognostic Value of Non-coding RNA in Breast CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.